Abstract
The objective of this study was to assess the frequency of blood culture (BC) collection among neonates who received vancomycin. Demographic, clinical, microbiologic, and pharmacy data were collected for 1275 neonates (postnatal age 0–27 days) who received vancomycin at an Intermountain Healthcare facility between 1/2006 and 9/2011. Neonates treated with vancomycin had a BC collected 94 % (n = 1198) of the time, of which 37 % (n = 448) grew one or more bacterial organisms (BC positive). Of these, 1 % (n = 5) grew methicillin-resistant Staphylococcus aureus (MRSA), 71 % (n = 320) grew coagulase-negative Staphylococci (CoNS), 9 % (n = 40) grew methicillin-sensitive Staphylococcus aureus (MSSA), and 22 % (n = 97) grew other bacterial species (total exceeds 100 % due to co-detection). In patients with negative BC or no BC, vancomycin therapy was extended beyond 72 h 52 % of the time. The median duration of vancomycin therapy for patients with a negative BC was 4 (IQR: 2–10) days. BCs were frequently obtained among neonates who received vancomycin. Vancomycin therapy beyond the conventional ‘empiric’ treatment window of 48–72 h was common without isolation of resistant gram-positive bacteria.
Similar content being viewed by others
Abbreviations
- MRSA:
-
Methicillin-resistant Staphylococcus aureus
- CoNS:
-
Coagulase-negative Staphylococcus
- MSSA:
-
Methicillin-sensitive Staphylococcus aureus
References
Craft AP, Finer NN, Barrington KJ. Vancomycin for prophylaxis against sepsis in preterm neonates. Cochrane Database Syst Rev 2000: CD001971
Rana D, Abughali N, Kumar D, Super DM, Jacobs, Kumar ML (2012) Staphylococcus aureus, including community-acquired methicillin-resistant S. aureus, in a level III NICU: 2001 to 2008. Am J Perinatol 29:401–408
Prabaker K, Weinstein RA (2011) Trends in antimicrobial resistance in intensive care units in the United States. Curr Opin Crit Care 17:472–479
Bizzarro MJ, Gallagher PG (2007) Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol 31:26–32
Lawrence SL, Roth V, Slinger R, Toye B, Gaboury I, Lemyre B (2005) Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr 5:49
Johnson PJ (2012) Antibiotic resistance in the NICU. Neonatal Netw 31:109–114
Brilene T, Soeorg H, Kiis M, Sepp E, Koljalg S, Loivukene K, Jurna-Ellam M, Kalinina J, Stsepetova J, Metsvaht T, Lutsar I (2013) In vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsis. Apmis 121:859–864
van Hal SJ, Paterson DL, Lodise TP (2013) Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother 57:734–744
Chiu CH, Michelow IC, Cronin J, Ringer SA, Ferris TG, Puopolo KM (2011) Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J 30:273–278
Di Pentima MC, Chan S (2010) Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J 29:707–711
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, M JR, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011; 52: e18-55
Hall KK, Lyman JA (2006) Updated review of blood culture contamination. Clin Microbiol Rev 19:788–802
Paolucci M, Landini MP, Sambri V (2012) How can the microbiologist help in diagnosing neonatal sepsis? Int J Pediatr 2012:120139
Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG (2003) Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 22:430–434
Guerti K, Devos H, Ieven MM, Mahieu LM (2011) Time to positivity of neonatal blood cultures: fast and furious? J Med Microbiol 60:446–453
Christensen JE, Stencil JA, Reed KD (2003) Rapid identification of bacteria from positive blood cultures by terminal restriction fragment length polymorphism profile analysis of the 16S rRNA gene. J Clin Microbiol 41:3790–3800
Kumar Y, Qunibi M, Neal TJ, Yoxall CW (2001) Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 85:F182–F186
Kerur B, Salvador A, Arbeter A, Schutzman DL (2012) Neonatal blood cultures: survey of neonatologists’ practices. World journal of pediatrics : WJP 8:260–262
Decamp LR, Dempsey AF, Tarini BA (2009) Neonatal sepsis: looking beyond the blood culture: evaluation of a study of universal primer polymerase chain reaction for identification of neonatal sepsis. Arch Pediatr Adolesc Med 163:12–14
Edmond K, Zaidi A (2010) New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med 7:e1000213
Sherwin C, Broadbent R, Young S, Worth J, McCaffrey F, Medlicott NJ, Reith D (2008) Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am J Perinatol 25:629–636
Jorgensen JH, Hindler JF (2007) New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis 44:280–286
Klein JO. Infectious diseases of the fetus and newborn infant. PA, 2011
Cantey JB, Sanchez PJ (2011) Prolonged antibiotic therapy for “culture-negative” sepsis in preterm infants: it’s time to stop! The Journal of pediatrics 159:707–708
Heffner AC, Horton JM, Marchick MR, Jones AE (2010) Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin infect dis 50:814–820
Lynch TJ (2012) Choosing optimal antimicrobial therapies. Med Clin North Am 96:1079–1094
Isaacman DJ, Karasic RB, Reynolds EA, Kost SI (1996) Effect of number of blood cultures and volume of blood on detection of bacteremia in children. J pediatr 128:190–195
Paisley JW, Lauer BA (1994) Pediatric blood cultures. Clin lab med 14:17–30
Sarkar S, Bhagat I, DeCristofaro JD, Wiswell TE, Spitzer AR (2006) A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis. J perinatol 26:18–22
Improvement IfH. Blood cultures obtained prior to antibiotic administration. In, 2011
Pazin GJ, Saul S, Thompson ME (1982) Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med 142:263–268
Acknowledgments
None.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yakub, S.Y., Constance, J.E., Stockmann, C. et al. Epidemiological Evaluation of Blood Culture Patterns among Neonates Receiving Vancomycin. Indian J Microbiol 54, 389–395 (2014). https://doi.org/10.1007/s12088-014-0478-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-014-0478-4